6) Recently US industry groups recently claimed the Indian government offered them a “private” assurance that compulsory licences will not be issued, save in emergencies and for non-commercial purposes. What are the implications for patients and generic drug makers in India if government stops issuing compulsory licences. Critically examine.

Topic: IPR related issues

6) Recently US industry groups recently claimed the Indian government offered them a “private” assurance that compulsory licences will not be issued, save in emergencies and for non-commercial purposes. What are the implications for patients and generic drug makers in India if government stops issuing compulsory licences. Critically examine. (200 Words)

The Indian Express